Without question, 2022 has continued a years-long streak of uncertainty and change. We have become accustomed to upheaval, constant pivoting, and retooling processes and procedures in all areas to ...
It’s that time again. As 2022 has come and (almost) gone, it’s time to look back at the exciting grants and surprising denials of certiorari petitions involving patent and trademark matters by the ...
KANSAS CITY, Mo.--(BUSINESS WIRE)--CorEnergy Infrastructure Trust, Inc. (NYSE: CORR, CORRPrA) ("CorEnergy" or the "Company") today announced financial results for the fourth quarter and year ended ...
ZURICH, March 8 (Reuters) - Geberit GEBN.S posted better than expected net profit in 2022, the Swiss plumbing supplier said on Wednesday, as higher raw materials costs weighed, adding that a uncertain ...
Plains’ fourth-quarter results met our expectations but its 2022 outlook was disappointing. Our $13 fair value estimate and narrow moat remain unchanged after updating our model, as the increase from ...
Planned re-submission of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) Biologics License Application (BLA) to U.S. Food and Drug Administration (FDA) on track ISELIN, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback